Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Doximity (DOCS) Q4 Earnings: What To Expect

February 05, 2025 at 08:04 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

DOCS Cover Image

Healthcare professional network Doximity (NYSE: DOCS) will be announcing earnings results tomorrow afternoon. Here’s what you need to know.

Doximity beat analysts’ revenue expectations by 6.6% last quarter, reporting revenues of $136.8 million, up 20.4% year on year. It was a very strong quarter for the company, with EBITDA guidance for next quarter exceeding analysts’ expectations.

Is Doximity a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Doximity’s revenue to grow 13.8% year on year to $153.9 million, slowing from the 17.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.34 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Doximity has missed Wall Street’s revenue estimates twice over the last two years.

Looking at Doximity’s peers in the vertical software segment, only Agilysys has reported results so far. It missed analysts’ revenue estimates by 5.2%, delivering year-on-year sales growth of 14.9%. The stock was down 20.1% on the results.

Read our full analysis of Agilysys’s earnings results here.

There has been positive sentiment among investors in the vertical software segment, with share prices up 6.4% on average over the last month. Doximity is up 5.3% during the same time and is heading into earnings with an average analyst price target of $55.59 (compared to the current share price of $59.26).

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article